Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
Dual antiplatelet therapy (DAPT) has represented for decades the cornerstone of treatment for the prevention of ischemic complications, including stent thrombosis, in patients undergoing percutaneous coronary intervention (PCI). Despite the evolution in stent technologies, which has allowed the reduction in the minimum required duration of DAPT, the optimal duration of DAPT to ensure the best safety and efficacy still remains largely debated. Indeed, the results from investigations regarding the optimal DAPT duration based on stent type is limited.
Source: Progress in Cardiovascular Diseases - Category: Cardiology Authors: Jae Youn Moon, Francesco Franchi, Fabiana Rollini, Dominick J. Angiolillo Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Thrombosis